Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bladder cancer
Pharma
AZ's perioperative Imfinzi extends life in bladder cancer type
Imfinzi's survival win in muscle-invasive bladder cancer came from a perioperative regimen, a design that's been criticized by the FDA in lung cancer.
Angus Liu
Sep 15, 2024 10:30am
AstraZeneca's Imfinzi counts a trial win and a miss
Jun 25, 2024 11:00am
Pfizer sees 8 blockbuster cancer drugs from each focus area
Jun 13, 2024 12:45pm
Gilead's Trodelvy suffers double whammy
May 30, 2024 6:20pm
Merck's BCG monopoly could end
May 3, 2024 10:50am
Merck KGaA, Huma roll out bladder cancer patient support app
Apr 29, 2024 11:55am
